Small molecules and biologicals in cancer immunotherapy
| Start | |
| 09.30 | Registration and coffee |
| 09.45 | Welcome and Opening symposium |
| 09.50 | Andrea van Elsas (Aduro Biotech, NL) Cancer immunotherapy beyond PD-1 |
| 10.30 | Benoit Van den Eynde (Ludwig Institute for Cancer Research, BE): Targeting IDO and TDO with small molecules to improve cancer immunotherapy |
| 11.10 | Short break |
| 11.30 | Alexander Dömling (University of Groningen, NL): Discovery, structural basis and biological activity of highly potent small molecule PDL1 binders |
| 12.00 | Rob de Jong (GenMab, NL): Improving immunotherapy, inspired by nature: DuoBody technology and applications |
| 12.30 | Lunch and “ALV KNCV Sectie Farmacochemie” |
| 13.30 |  Winner of the Dutch Medicinal Chemistry award for the best PhD thesis.Sponsored by Mercachem |
| 14.10 | Jolanda de Vries (Radboud UMC, NL): Dendritic cell based vaccination against cancer: Current status and future prospects |
| 14.40 | Short break |
| 14.55 | Huib Ovaa (LUMC, NL): Assay and drug development to target the ubiquitin system |
| 15.25 | Geert-Jan Boons (Utrecht University, NL): Synthetic vaccines and immune modulators for cancer |
| 15.55 | Yvette van Kooyk (VUmc, NL) Glycans for the design of cancer vaccines and checkpoint inhibition |
| 16.25 | Closure and Drinks |
